ArcticZymes Technologies ASA (OSTO:BIOTECO) Piotroski F-Score: 8 (As of Aug. 27, 2026) — 60% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:BIOTECO ArcticZymes Technologies ASA OSTO:BIOTECO
77 GF Score
Price kr21.00
GF Value kr25.94
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is ArcticZymes Technologies ASA Piotroski F-Score?

ArcticZymes Technologies ASA OSTO:BIOTECO 77 Piotroski F-Score is 8 as of Aug. 27, 2026, which is 60% above its 10-year median of 5.00. GuruFocus rates OSTO:BIOTECO with a GF Score™ of 77/100 and a GF Value™ of kr25.94 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 1,341 Biotechnology companies, ArcticZymes Technologies ASA ranks better than 99.25% on this metric.

Good Sign:

Piotroski F-Score is 8, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

ArcticZymes Technologies ASA has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for ArcticZymes Technologies ASA's Piotroski F-Score or its related term are showing as below:

OSTO:BIOTECO' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 5   Max: 8
Current: 8

During the past 13 years, the highest Piotroski F-Score of ArcticZymes Technologies ASA was 8. The lowest was 3. And the median was 5.

ArcticZymes Technologies ASA  (OSTO:BIOTECO) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


ArcticZymes Technologies ASA Piotroski F-Score Related Terms


ArcticZymes Technologies ASA Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for ArcticZymes Technologies ASA's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ArcticZymes Technologies ASA Piotroski F-Score Chart

ArcticZymes Technologies ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.00 5.00 6.00 4.00 8.00

ArcticZymes Technologies ASA Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 7.00 8.00 6.00 8.00

OSTO:BIOTECO vs VRTX, REGN, RVMD: Piotroski F-Score Comparison

For the Biotechnology subindustry, ArcticZymes Technologies ASA's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ArcticZymes Technologies ASA Piotroski F-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ArcticZymes Technologies ASA's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where ArcticZymes Technologies ASA's Piotroski F-Score falls into.


OSTO:BIOTECO
77GF Score
ArcticZymes Technologies ASA OSTO:BIOTECO
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun26) TTM:Last Year (Jun25) TTM:
Net Income was 3.297 + 6.868 + 0.585 + 5.25 = kr16.0 Mil.
Cash Flow from Operations was 11.929 + 8.645 + 0.208 + 7.906 = kr28.7 Mil.
Revenue was 28.518 + 34.084 + 31.77 + 31.887 = kr126.3 Mil.
Gross Profit was 27.838 + 32.535 + 29.619 + 30.34 = kr120.3 Mil.
Average Total Assets from the begining of this year (Jun25)
to the end of this year (Jun26) was
(349.344 + 352.974 + 361.268 + 375.102 + 379.111) / 5 = kr363.5598 Mil.
Total Assets at the begining of this year (Jun25) was kr349.3 Mil.
Long-Term Debt & Capital Lease Obligation was kr14.5 Mil.
Total Current Assets was kr312.9 Mil.
Total Current Liabilities was kr17.7 Mil.
Net Income was -1.558 + 3.181 + -3.109 + 3.282 = kr1.8 Mil.

Revenue was 23.318 + 24.539 + 23.258 + 26.757 = kr97.9 Mil.
Gross Profit was 22.316 + 22.958 + 22.378 + 25.182 = kr92.8 Mil.
Average Total Assets from the begining of last year (Jun24)
to the end of last year (Jun25) was
(338.959 + 341.752 + 345.272 + 343.315 + 349.344) / 5 = kr343.7284 Mil.
Total Assets at the begining of last year (Jun24) was kr339.0 Mil.
Long-Term Debt & Capital Lease Obligation was kr4.6 Mil.
Total Current Assets was kr290.0 Mil.
Total Current Liabilities was kr18.2 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

ArcticZymes Technologies ASA's current Net Income (TTM) was 16.0. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

ArcticZymes Technologies ASA's current Cash Flow from Operations (TTM) was 28.7. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Jun25)
=16/349.344
=0.04580013

ROA (Last Year)=Net Income/Total Assets (Jun24)
=1.796/338.959
=0.00529858

ArcticZymes Technologies ASA's return on assets of this year was 0.04580013. ArcticZymes Technologies ASA's return on assets of last year was 0.00529858. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

ArcticZymes Technologies ASA's current Net Income (TTM) was 16.0. ArcticZymes Technologies ASA's current Cash Flow from Operations (TTM) was 28.7. ==> 28.7 > 16.0 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Jun26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun25 to Jun26
=14.548/363.5598
=0.04001543

Gearing (Last Year: Jun25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun24 to Jun25
=4.616/343.7284
=0.01342921

ArcticZymes Technologies ASA's gearing of this year was 0.04001543. ArcticZymes Technologies ASA's gearing of last year was 0.01342921. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Jun26)=Total Current Assets/Total Current Liabilities
=312.919/17.697
=17.6820365

Current Ratio (Last Year: Jun25)=Total Current Assets/Total Current Liabilities
=289.993/18.237
=15.90135439

ArcticZymes Technologies ASA's current ratio of this year was 17.6820365. ArcticZymes Technologies ASA's current ratio of last year was 15.90135439. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

ArcticZymes Technologies ASA's number of shares in issue this year was 52.5. ArcticZymes Technologies ASA's number of shares in issue last year was 54.7. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=120.332/126.259
=0.95305681

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=92.834/97.872
=0.9485246

ArcticZymes Technologies ASA's gross margin of this year was 0.95305681. ArcticZymes Technologies ASA's gross margin of last year was 0.9485246. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Jun25)
=126.259/349.344
=0.3614174

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Jun24)
=97.872/338.959
=0.28874289

ArcticZymes Technologies ASA's asset turnover of this year was 0.3614174. ArcticZymes Technologies ASA's asset turnover of last year was 0.28874289. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+0+1+1+1+1
=8

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

ArcticZymes Technologies ASA has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 8 mean?
ArcticZymes Technologies ASA (OSTO:BIOTECO) has a Piotroski F-Score of 8 as of Aug. 27, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on ArcticZymes Technologies ASA and its competitors. This is 60% above median its historical median of 5.00. Over the past decade, ArcticZymes Technologies ASA's Piotroski F-Score has ranged from 3.00 to 8.00. According to the industry distribution chart, ArcticZymes Technologies ASA ranks #10 out of 1341 companies in the Biotechnology industry, placing it in the top 0.7%.
Is ArcticZymes Technologies ASA's Piotroski F-Score too high?
ArcticZymes Technologies ASA's current Piotroski F-Score of 8 is 60% above median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 8.00. The Biotechnology industry median Piotroski F-Score is 3.00. ArcticZymes Technologies ASA's value of 8 is 166.7% above this industry median. Based on the distribution chart, ArcticZymes Technologies ASA ranks #10 out of 1341 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, ArcticZymes Technologies ASA has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ArcticZymes Technologies ASA's Piotroski F-Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, ArcticZymes Technologies ASA ranks #10 out of 1341 companies for Piotroski F-Score. This places ArcticZymes Technologies ASA in the top 1% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 3.00. ArcticZymes Technologies ASA's value of 8 is 166.7% above this benchmark. Historically, ArcticZymes Technologies ASA's own Piotroski F-Score has ranged from 3.00 to 8.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 3.00, ArcticZymes Technologies ASA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Biotechnology company?
The median Piotroski F-Score among Biotechnology companies is 3.00, based on 1,341 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ArcticZymes Technologies ASA's current Piotroski F-Score of 8 is 166.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on ArcticZymes Technologies ASA and its competitors. For the Biotechnology industry, the median Piotroski F-Score is 3.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ArcticZymes Technologies ASA's current Piotroski F-Score is 8, which is 60% above median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ArcticZymes Technologies ASA stock overvalued right now?
Based on GuruFocus' analysis, ArcticZymes Technologies ASA (OSTO:BIOTECO) is currently considered Modestly Undervalued. The stock's GF Value™ is kr25.94, compared to a current price of kr21.00 — trading 19% below its estimated fair value. The current Piotroski F-Score is 8, which is 60% above median its 10-year median of 5.00 and 166.7% above the Biotechnology industry median of 3.00. ArcticZymes Technologies ASA's overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For ArcticZymes Technologies ASA (OSTO:BIOTECO), the current Piotroski F-Score is 8 as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ArcticZymes Technologies ASA (OSTO:BIOTECO) Overvalued in 2026?

Based on GuruFocus' analysis, ArcticZymes Technologies ASA stock appears to be undervalued. The current stock price of kr21.00 is trading 19% below its estimated GF Value™ of kr25.94. GuruFocus considers ArcticZymes Technologies ASA to be Modestly Undervalued.

Key valuation signals for OSTO:BIOTECO:

  • Piotroski F-Score: 8 (60% above median its 10-year median of 5.00)
  • GF Value™: kr25.94 vs. price of kr21.00 (19% below fair value)
  • GF Score™: 77/100 with 1 warning sign
  • Industry Position: 166.7% above the Biotechnology median (#10 of 1341)

No single metric tells the full story. See the OSTO:BIOTECO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ArcticZymes Technologies ASA Business Description

Other Exchanges AZT:Norway0DRV:UK
Address Sykehusveien 23, Tromso, NOR, 9294
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments, Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA followed by Lithuania, Norway, Germany, France, Italy, UK, Other countries in Europe, and Rest of world.
77GF Score

Get the complete analysis for OSTO:BIOTECO

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr21.00
Price
kr25.94
GF Value